ITNS.US Itonis Inc

Healthcare Health Care Providers & Services USA Stocks
0.0004 USD
Close of Oct 22, 2026
0.0002 0.0006
Market cap
USD 609K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Aug 2026.

Is ITNS.US undervalued?

Graham number

The Graham number of Itonis Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Itonis Inc fundamental analysis

No fundamental analysis for Itonis Inc yet.

Itonis Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Itonis Inc

Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was fou…

Full company profile